Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2016

Feb 16, 2016

30237_dirs_2016-02-16_7e461c0c-67c9-4736-96cd-b011ecacde68.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2016-02-11

Reporting Person: KING DAVID P (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-11 Common Stock M 8343 Acquired 89551.2512 Direct
2016-02-11 Common Stock F 2768 $101.40 Disposed 86783.2512 Direct
2016-02-12 Common Stock M 8270 Acquired 95053.2512 Direct
2016-02-12 Common Stock F 3735 $103.02 Disposed 91318.2512 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-11 Restricted Stock Unit $ M 8343 Disposed Common Stock (8343) Direct
2016-02-12 Restricted Stock Unit $ M 8270 Disposed Common Stock (8270) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 24383 Indirect
Common Stock 19046 Indirect

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Amount includes 54.8037 shares acquired on December 31, 2015 under the Laboratory Corporation of America Holdings 1997 Employee Stock Purchase Plan.

F3: Stock withholding to satisfy tax withholding obligations.

F4: The Restricted Stock Units vest in three equal annual installments beginning on 2/11/2015.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F6: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2014.